AlphaYou
Overview
Smart money at a glance
Filings to Oct 12, 2026Net buying: insiders sold $0 and bought $692K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$692K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 12- Open
- $0.39
- 52-wk high
- $1.49
- High
- $0.41
- 52-wk low
- $0.35
- Low
- $0.38
- Prev close
- $0.41
- Mkt cap
- $6.0M
- Volume
- 88.3K
- Beta
- 0.72
- P/S
- 3.6x
- P/B
- 4.7x
- Profit margin
- +0.0%
- Op margin
- -607.0%
- ROE
- -182.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about EVGN filings
Are insiders buying or selling Evogene (EVGN) stock?
Net buying: insiders sold $0 and bought $692K of EVGN stock on the open market in the 90 days to Oct 12, 2026, according to SEC Form 4 filings. The largest was Recanati, Leon (Director), who bought $692K. The latest filing was on Aug 13, 2026.
Which members of Congress have traded EVGN recently?
None. No member of Congress disclosed a EVGN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this EVGN smart-money data?
This summary uses filings available on Oct 12, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
2 funds hold a position and insiders have been net buying.
What insiders are doing
Buys (3)
- TG
Tarcic Gabi
$677
bought
- RL
Recanati Leon
$292K
bought
- RL
Recanati Leon
$400K
bought
How top traders are positioned
No tracked top-trader positions in EVGN right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 51.9% above what analysts expected.
Last report
Aug 18, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.27 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 18, 2026 | -$0.13 / -$0.27Alpha Vantage | +51.85% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 20, 2026 | -$0.61 / -$0.27Alpha Vantage | -125.93% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 5, 2026 | -$0.62 / -$0.41Alpha Vantage | -50.59% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 20, 2025 | -$0.46 / -$0.41Alpha Vantage | -12.20% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 28, 2025 | -$0.50 / -$0.63Alpha Vantage | +20.63% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 21, 2025 | -$0.38 / -$0.50Alpha Vantage | +24.00% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 6, 2025 | $0.06 / -$0.72Alpha Vantage | +108.28% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 21, 2024 | -$1.31 / -$1.01Alpha Vantage | -29.70% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 19, 2026, in 38 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $6M
Valuation
- P/S3.65
- P/B4.71
Quality
- Operating margin-607.0%
- ROE-182.7%
- ROA-37.5%
Growth
- Beta0.72
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace